Aehr Test Systems Framtida tillväxt

Future kriterier kontrolleras 2/6

Aehr Test Systems förväntas öka intäkter och intäkter med 43.2% respektive 20.7% per år.

Viktig information

43.2%

Tillväxttakt i vinsten

n/a

Tillväxttakt för EPS

Semiconductor vinsttillväxt	25.2%
Intäkternas tillväxttakt	20.7%
Framtida avkastning på eget kapital	n/a
Bevakning av analytiker	Low
Senast uppdaterad	17 Dec 2025

Senaste uppdateringarna om framtida tillväxt

Recent updates

Aehr Test Systems, Inc. (NASDAQ:AEHR) Shares May Have Slumped 31% But Getting In Cheap Is Still Unlikely

Nov 20

There's Reason For Concern Over Aehr Test Systems, Inc.'s (NASDAQ:AEHR) Massive 29% Price Jump

Aug 28

Aehr Test Systems Heads Into A Critical Year

Aug 26

Calculating The Intrinsic Value Of Aehr Test Systems, Inc. (NASDAQ:AEHR)

Aug 20

Further Upside For Aehr Test Systems, Inc. (NASDAQ:AEHR) Shares Could Introduce Price Risks After 34% Bounce

Jul 09

Aehr Test Systems will leverage AI for significant growth potential

Jun 27There are a couple of reasons that I like this stock, but I still need to look more into it, however I do currently own some shares. As of right now AEHR is in a good position with AI about to explode

Aehr Test Systems: An Earnings Show-Me Story, Optimistic For A Turnaround

Mar 27

Not Many Are Piling Into Aehr Test Systems, Inc. (NASDAQ:AEHR) Stock Yet As It Plummets 34%

Feb 06

Aehr Test Systems: Selloff Was Justified But I'm Still Cautiously Optimistic (Rating Downgrade)

Jan 16

Aehr Test Systems: With A Turnaround In Sight, It's High On My Watchlist To Build A Proper Position

Dec 17

Improved Earnings Required Before Aehr Test Systems, Inc. (NASDAQ:AEHR) Stock's 34% Jump Looks Justified

Dec 17

Aehr Test Systems' (NASDAQ:AEHR) Earnings Might Not Be As Promising As They Seem

Oct 23

Aehr Test Systems, Inc.'s (NASDAQ:AEHR) Shares Bounce 30% But Its Business Still Trails The Market

Oct 19

We Like These Underlying Return On Capital Trends At Aehr Test Systems (NASDAQ:AEHR)

Jun 06

Why Aehr Test Systems (NASDAQ:AEHR) Could Be Worth Watching

May 01

Aehr Test Systems' (NASDAQ:AEHR) Solid Earnings May Rest On Weak Foundations

Apr 18

Some Confidence Is Lacking In Aehr Test Systems (NASDAQ:AEHR) As Shares Slide 30%

Apr 01

Investors Shouldn't Overlook Aehr Test Systems' (NASDAQ:AEHR) Impressive Returns On Capital

Feb 21

Aehr Test Systems Faces Cyclical Headwinds (Rating Downgrade)

Feb 14

Should You Investigate Aehr Test Systems (NASDAQ:AEHR) At US$14.85?

Feb 01

Aehr Test Systems: Revised Guidance Likely To Be Lowered Again - Sell

Jan 11

Aehr Test Systems' (NASDAQ:AEHR) Shareholders Might Be Looking For Exit

Jan 03

Does Aehr Test Systems (NASDAQ:AEHR) Deserve A Spot On Your Watchlist?

Dec 16

Aehr Test Systems (NASDAQ:AEHR) Is Very Good At Capital Allocation

Oct 17

Calculating The Fair Value Of Aehr Test Systems (NASDAQ:AEHR)

Sep 13

Prognoser för vinst- och omsättningstillväxt

NasdaqCM:AEHR - Analytikernas framtida uppskattningar och tidigare finansiella data (USD Millions )
Datum	Intäkter	Intäkter	Fritt kassaflöde	Kassaflöde från rörelsen	Genomsnittligt Antal analytiker
5/31/2028	101	N/A	N/A	N/A	1
5/31/2027	80	-3	N/A	N/A	4
5/31/2026	59	-7	N/A	N/A	4
8/29/2025	57	-7	-16	-10	N/A
5/30/2025	59	-4	-12	-7	N/A
2/28/2025	61	23	-6	-4	N/A
11/29/2024	51	22	-6	-5	N/A
8/30/2024	59	29	0	0	N/A
5/31/2024	66	33	1	2	N/A
2/29/2024	72	15	5	6	N/A
11/30/2023	82	21	6	8	N/A
8/31/2023	75	19	7	8	N/A
5/31/2023	65	15	9	10	N/A
2/28/2023	63	14	3	3	N/A
11/30/2022	61	12	1	2	N/A
8/31/2022	56	9	5	5	N/A
5/31/2022	51	9	1	2	N/A
2/28/2022	38	4	2	2	N/A
11/30/2021	28	1	5	5	N/A
8/31/2021	20	-1	-2	-1	N/A
5/31/2021	17	-2	-3	-3	N/A
2/28/2021	13	-5	-4	-4	N/A
11/30/2020	14	-4	-4	-4	N/A
8/31/2020	19	-2	-1	-1	N/A
5/31/2020	22	-3	-2	-2	N/A
2/29/2020	26	0	-2	-1	N/A
11/30/2019	23	-3	-3	-3	N/A
8/31/2019	22	-4	-5	-5	N/A
5/31/2019	21	-5	N/A	-6	N/A
2/28/2019	21	-5	N/A	-3	N/A
11/30/2018	25	-2	N/A	-2	N/A
8/31/2018	27	-1	N/A	2	N/A
5/31/2018	30	1	N/A	-1	N/A
2/28/2018	29	0	N/A	-3	N/A
11/30/2017	24	-3	N/A	-5	N/A
8/31/2017	21	-5	N/A	-10	N/A
5/31/2017	19	-6	N/A	-4	N/A
2/28/2017	14	-8	N/A	-6	N/A
11/30/2016	13	-8	N/A	-4	N/A
8/31/2016	13	-8	N/A	-3	N/A
5/31/2016	15	-7	N/A	-6	N/A
2/29/2016	15	-6	N/A	-5	N/A
11/30/2015	15	-4	N/A	-5	N/A
8/31/2015	13	-5	N/A	-4	N/A
5/31/2015	10	-7	N/A	-2	N/A
2/28/2015	14	-5	N/A	-2	N/A

Analytiker Framtid Tillväxt Prognoser

Intäkter kontra sparande: AEHR förväntas förbli olönsam under de kommande 3 åren.

Resultat vs marknad: AEHR förväntas förbli olönsam under de kommande 3 åren.

Höga tillväxtresultat: AEHR förväntas förbli olönsam under de kommande 3 åren.

Intäkt vs marknad: AEHR s intäkter ( 20.7% per år) förväntas växa snabbare än US marknaden ( 10.7% per år).

Hög tillväxtintäkter: AEHR s intäkter ( 20.7% per år) förutspås växa snabbare än 20% per år.

Tillväxtprognoser för vinst per aktie

Framtida avkastning på eget kapital

Framtida ROE: Otillräcklig data för att avgöra om AEHR s avkastning på eget kapital förväntas bli hög om tre år

Upptäck tillväxtföretag

Företagsanalys och finansiella data Status

Uppgifter	Senast uppdaterad (UTC-tid)
Analys av företag	2025/12/24 21:34
Aktiekurs vid dagens slut	2025/12/24 00:00
Intäkter	2025/08/29
Årlig intjäning	2025/05/30

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

Paket	Uppgifter	Tidsram	Exempel US-källa
Företagets finansiella ställning	10 år	Resultaträkning Kassaflödesanalys Balansräkning	SEC Form 10-K SEC Form 10-Q
Analytikernas konsensusuppskattningar	+3 år	Prognos för finansiella poster Analytikernas prismål	Rapporter från analytiker Blue Matrix
Marknadspriser	30 år	Aktiekurser Utdelningar, splittar och åtgärder	ICE Marknadsdata SEC Form S-1
Ägarskap	10 år	Största aktieägare Insiderhandel	SEC Formulär 4 SEC Formulär 13D
Förvaltning	10 år	Ledningsgrupp Styrelse och verkställande direktörer	SEC Form 10-K SEC Form DEF 14A
Viktiga utvecklingstendenser	10 år	Företagsmeddelanden	SEC Formulär 8-K

^* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om den analysmodell som används för att generera denna rapport finns på vår Github-sida, vi har också guider om hur man använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Aehr Test Systems, Inc. bevakas av 4 analytiker. 4 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

Analytiker	Institution
Christian Schwab	Craig-Hallum Capital Group LLC
Egor Tolmachev	Freedom Broker
Maxwell Michaelis	Lake Street Capital Markets, LLC

Aehr Test Systems Framtida tillväxt

Future kriterier kontrolleras 2/6

Viktig information

Senaste uppdateringarna om framtida tillväxt

Price target decreased by 24% to US$19.00

Aehr Test Systems Reiterates Earnings Guidance for Fiscal Year Ending May 30, 2025

Aehr Test Systems, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ending May 30, 2025

Price target increased by 108% to US$25.00

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 30, 2025

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Recent updates

Now 25% overvalued after recent price rise

Aehr Test Systems, Inc. (NASDAQ:AEHR) Shares May Have Slumped 31% But Getting In Cheap Is Still Unlikely

Independent Director recently sold US$154k worth of stock

Insider exercised options to buy US$2.8m worth of stock.

Independent Director recently sold US$223k worth of stock

First quarter 2026 earnings released: US$0.07 loss per share (vs US$0.023 profit in 1Q 2025)

Aehr Test Systems, Inc. to Report Q1, 2026 Results on Oct 06, 2025

Aehr Test Systems, Inc., Annual General Meeting, Oct 20, 2025

New major risk - Share price stability

There's Reason For Concern Over Aehr Test Systems, Inc.'s (NASDAQ:AEHR) Massive 29% Price Jump

Aehr Test Systems Heads Into A Critical Year

Now 44% overvalued after recent price rise

Calculating The Intrinsic Value Of Aehr Test Systems, Inc. (NASDAQ:AEHR)

Independent Director recently sold US$108k worth of stock

Founder & Independent Chairman notifies of intention to sell stock

New minor risk - Insider selling

Now 30% undervalued

Further Upside For Aehr Test Systems, Inc. (NASDAQ:AEHR) Shares Could Introduce Price Risks After 34% Bounce

Insufficient new directors

Aehr Test Systems, Inc. to Report Q4, 2025 Results on Jul 08, 2025

Aehr Test Systems will leverage AI for significant growth potential

Third quarter 2025 earnings released: US$0.022 loss per share (vs US$0.051 loss in 3Q 2024)

Investor sentiment deteriorates as stock falls 20%

Aehr Test Systems, Inc. to Report Q3, 2025 Results on Apr 08, 2025

Aehr Test Systems: An Earnings Show-Me Story, Optimistic For A Turnaround

Investor sentiment improves as stock rises 20%

Investor sentiment improves as stock rises 22%

Not Many Are Piling Into Aehr Test Systems, Inc. (NASDAQ:AEHR) Stock Yet As It Plummets 34%

Investor sentiment deteriorates as stock falls 22%

Price target decreased by 24% to US$19.00

Aehr Test Systems: Selloff Was Justified But I'm Still Cautiously Optimistic (Rating Downgrade)

Second quarter 2025 earnings released: US$0.035 loss per share (vs US$0.21 profit in 2Q 2024)

Aehr Test Systems Reiterates Earnings Guidance for Fiscal Year Ending May 30, 2025

Aehr Test Systems, Inc. to Report Q2, 2025 Results on Jan 13, 2025

Investor sentiment improves as stock rises 21%

Aehr Test Systems: With A Turnaround In Sight, It's High On My Watchlist To Build A Proper Position

Improved Earnings Required Before Aehr Test Systems, Inc. (NASDAQ:AEHR) Stock's 34% Jump Looks Justified

Investor sentiment improves as stock rises 17%

Gewirtz & Grossman LLC Notifies Class Action Lawsuit Filed Against Aehr Test Systems, Inc

Investor sentiment deteriorates as stock falls 17%

Aehr Test Systems' (NASDAQ:AEHR) Earnings Might Not Be As Promising As They Seem

Aehr Test Systems, Inc.'s (NASDAQ:AEHR) Shares Bounce 30% But Its Business Still Trails The Market

Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $40 million.

First quarter 2025 earnings released: EPS: US$0.023 (vs US$0.16 in 1Q 2024)

Aehr Test Systems, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ending May 30, 2025

Aehr Test Systems: Enthusiastic Management But Weak Near-Term Prospects, Hold

Aehr Test Systems, Inc. to Report Q1, 2025 Results on Oct 10, 2024

Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024

Aehr Test Systems (NASDAQ:AEHR) Is Experiencing Growth In Returns On Capital

Investor sentiment deteriorates as stock falls 19%

Independent Director recently sold US$186k worth of stock

Price target increased by 108% to US$25.00

Full year 2024 earnings released: EPS: US$1.15 (vs US$0.52 in FY 2023)

Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1.

Aehr Test Systems' (NASDAQ:AEHR) 27% Share Price Surge Not Quite Adding Up

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 30, 2025

Investor sentiment improves as stock rises 40%

Aehr Test Systems to Report Q4, 2024 Results on Jul 16, 2024

Now 23% overvalued

Investor sentiment deteriorates as stock falls 18%

Now 20% overvalued

New minor risk - Share price stability

Aehr Test Systems: The Bottom Might Be In

We Like These Underlying Return On Capital Trends At Aehr Test Systems (NASDAQ:AEHR)

Investor sentiment improves as stock rises 15%

Insufficient new directors

Why Aehr Test Systems (NASDAQ:AEHR) Could Be Worth Watching

Now 24% overvalued

Aehr Test Systems' (NASDAQ:AEHR) Solid Earnings May Rest On Weak Foundations